Table 3.
Characteristic | Characteristic sub-groups | Malhotra et al.(25) | Flechet et al.*(26) | Deng et al.†(28) | Chiofolo et al.(29) | Zimmerman et al.‡(30) |
---|---|---|---|---|---|---|
Biomarkers used for comparison | Not applicable | sNGAL | sCysC and uNAG | Not applicable | Not applicable | |
Discrimination of biomarkers (AUROC) | Not applicable | For NGAL in validation NGAL cohort: 0.74 (0.74 - 0.74) | 0.756 (0.723 - 0.789) | Not applicable | Not applicable | |
Discrimination of prediction models (AUROC) | Development cohort | Not reported | 0.86 (0.86 - 0.86) | 0.821 (0.792 - 0.850) | 0.949 (0.943 - 0.954) | Not reported |
Internal validation cohort | 0.792 (0.697 - 0.887) | 0.86 (0.86 - 0.86) | 0.821 (0.792 - 0.850) | 0.882 (0.867 - 0.897) | 0.78 | |
External validation cohort | 0.81 (0.78 - 0.83) | 0.81 (0.81 - 0.81) | Not applicable | Not applicable | Not applicable | |
Discrimination of prediction models with biomarkers (AUROC) | Not applicable | For combined model in validation NGAL cohort: 0.80 (0.80 - 0.80) | 0.836 (0.808 - 0.864) | Not applicable | Not applicable |
sNGAL - serum neutrophil gelatinase-associated lipocalin; sCysC - serum cystatin C; uNAG - urinary N-acetyl-β-D-glucosaminidase; AUROC - area under the receiver operating characteristics; NGAL - neutrophil gelatinase-associated lipocalin.
Data from Flechet et al. are only reported for the prediction model for any acute kidney injury on the first day;
data from Deng et al. are only reported for the prediction model for any acute kidney injury;
data for Zimmerman et al. are only reported for the multivariate logistic regression model derived with backward selection.